Loading stock data…
Shattuck Labs, Inc. (STTK)
$6.79-0.17 (-2.44%)
Pre-Market$6.61-0.18 (-2.65%)· Last close Sep 4
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Shattuck Labs, Inc. in the Healthcare sector is trading at $6.50 with a market capitalization of $410M. Wall Street consensus targets $14.67 (9 analysts), implying a +125.6% move over the next 12 months. The stock is currently 22% below its 52-week high of $8.33, remaining 18.0% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +125.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0↓ | $1.00M | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$15.54M↓ | -$13.37M↓ | -$10.72M↑ | -$13.03M↑ | -$14.39M |
| Net Income | -$14.77M↓ | -$12.59M↓ | -$10.06M↑ | -$12.46M↑ | -$13.70M |
Peer Comparison
JNJUNHPFE
Fundamentals
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monocl...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$681.47M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.10
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-52.04%
Volume
Today's trading volume
677,763
Recent News
What Shattuck Labs Stock Topped the Market on Monday
Two analysts weighed in with new takes on the biotech.
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
The consensus price target hints at an 85.3% upside potential for Shattuck Labs (STTK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
An analyst initiated coverage of the biotech with a buy recommendation.
SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls
SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls